Quick Search
Products GW1929 (N-(2-Benzoylphenyl)-L-tyrosine PPARgamma Agonist, (2S)-((2-Benzoylphenyl)amino-3-phenyl]propionic acid)
![GW1929 (N-(2-Benzoylphenyl)-L-tyrosine PPARgamma Agonist, (2S)-((2-Benzoylphenyl)amino-3-phenyl]propionic acid)](/system/suppliers/default_product_images/000/000/160/main/US-Biological-Life-Sciences.jpg?1386100414)
| Catalogue number: | 044874 |
| Size: | 1mg |
| Purity: | >98% (NMR) |
| Alternative names: | N-(2-Benzoylphenyl)-L-tyrosine PPARgamma Agonist, (2S)-((2-Benzoylphenyl)amino-3-phenyl]propionic acid |
| References: | Product Reference: ?N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents: B.R. Henke, et al.; J. Med. Chem. 41, 5020 (1998) ?A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat: K.K. Brown, et al.; Diabetes 48, 1415 (1999) ?PPARgamma agonists inhibit angiogenesis by suppressing PKCalpha- and CREB-mediated COX-2 expression in the human endothelium: E. Scoditti, et al.; Cardiovasc. Res. 86, 302 (2010) ?Ameliorative Effects of GW1929, a Nonthiazolidinedione PPAR gamma Agonist, on Inflammation and Apoptosis in Focal Cerebral Ischemic-Reperfusion Injury: R.K. Kaundal & S.S. Sharma; Curr. Neurovasc. Res. 8, 236 (2011) ? |
Get the Best Promotions
